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ABSTRACT
Naturally occurring proteins in cellular networks
often share peptide motifs. These motifs have been
known to play a pivotal role in protein interactions
among the components of a network. However,
it remains unknown how these motifs have con-
tributed to the evolution of the protein network.
Here we addressed this issue by a synthetic biology
approach. Through the motif programming method,
we have constructed an artificial protein library
by mixing four peptide motifs shared among the
Bcl-2 family proteins that positively or negatively
regulate the apoptosis networks. We found one
strong pro-apoptotic protein, d29, and two proteins
having moderate, but unambiguous anti-apoptotic
functions, a10 and d16, from the 28 tested clones.
Thus both the pro- and anti-apoptotic modulators
were present in the library, demonstrating that
functional proteins with opposing effects can
emerge from a single pool prepared from common
motifs. Motif programming studies have exhibited
that the annotated function of the motifs were
significantly influenced by the context that the
motifs embedded. The results further revealed that
reshuffling of a set of motifs realized the promiscu-
ous state of protein, from which disparate functions
could emerge. Our finding suggests that motifs
contributed to the plastic evolvability of the protein
network.
INTRODUCTION
Protein regulatory networks that underlie various cell
activities have evolved with an autonomy and robustness
(1,2). The proteins that comprise regulatory networks
often share peptide motifs, a short conserved amino acid
sequence (3,4). Recently, with advent of high-throughput
proteomics, the identiﬁcation of peptide motifs has been
drastically accelerated (5,6). Motifs are often associated
with biological functions, protein structures or evolution-
ary history, and generally consist of short amino acids
(typically 5–25 amino acids). It has been reported that
several peptide motifs lose original biological functions
when they are isolated from their parental proteins,
indicating that peptide motifs are capricious, as they are
strongly inﬂuenced by their context within the proteins
(7,8). In contrast, protein domains often fold indepen-
dently of the rest of the protein chain, and typically consist
of more than 25 amino acids.
Some peptide motifs in a protein network have been
shown to be involved in the protein–protein interaction
in the network (9) thus they have a pivotal role in the
dynamics of the network (10,11) (Figure 1A). However,
it remains unknown how these motifs have contributed
to the evolution of the protein network. In this study, we
addressed this question by a synthetic biology approach
(12), in which a library of artiﬁcial proteins was created
from a combinatorial assembly of extant peptide motifs in
the apoptosis network and the pro- and anti-apoptotic
clones were searched from the library. We took synthetic
biology approach to investigate the role of peptide motifs
in the evolution of protein networks. Although the
classical top-down approach (i.e. the analyses of natural
proteins with a variety of combination of motifs; as
shown in Figure 1B) is crucial to elucidate the relation-
ship between motifs and protein functions, it is diﬃcult
to investigate whether the reshuﬄing of a set of motifs
can drastically change protein functions/localizations by
interfering with naturally occurring protein networks.
Thus we chose our motif programming approach to
generate such a motif-mixing protein library (12).
The peptide motifs we have been focusing on included
the BH1, BH2, BH3 and BH4 motifs, the combinations of
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the mitochondria-dependent apoptosis network (13–15).
The Bcl-2 family proteins are classiﬁed as ‘pro-apoptotic’
or ‘anti-apoptotic’ depending on their roles (Figure 1B,
left). The members are further divided into three classes
based on the BH1-4 motifs they contain (Figure 1B, right);
(i) multidomain members contain all four BH motifs
(Bcl-xL, Bcl-2, etc.). The members act as an anti-apoptotic
factor, (ii) multidomain members (Bax, Bak, etc.) that are
pro-apoptotic proteins and (iii) pro-apoptotic BH3-only
members (Bim, Noxa, etc.). As a ﬁrst approximation,
the motifs BH3 and BH4 are linked with the pro- and
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Figure 1. Exploring apoptotic regulatory networks by motif programming. (A) Schematic diagram of the roles of motifs in network evolution and
network dynamics. (B) (left) Apoptotic regulatory networks regulated by Bcl-2 family proteins. (right) Both anti-apoptotic and pro-apoptotic
proteins share the BH1-4 peptide motifs but the proteins vary with respect to the number of the four motifs. (C) Screening strategy of cell death
modulators utilized in this study. (left) Structure of human Bcl-xL, an anti-apoptotic multidomain protein [based on the (1R2D)]. The core regions of
the BH1, BH2, BH3 and BH4 motifs focused on in this study are shown in cyan, orange, red and green, respectively, though we used the BH3 motif
from Noxa instead of Bcl-xL. (middle) Four designed microgenes that encode BH peptides in their ﬁrst reading frames. (right) Cell-based screening
to identify artiﬁcial cell death modulators that oppositely regulate the apoptotic circuits (cell-killer or cell-protector).
6358 Nucleic Acids Research, 2007, Vol. 35, No. 19anti-apoptotic phenotypes, respectively. In fact, experi-
ments with synthetic peptides have shown that BH3 and
BH4 acted as apoptosis-inducing and apoptosis-protecting
agents, respectively (16–19). However, recent ﬁndings
are more equivocal. For example, Bcl-xL and Bcl-xS
share the same BH3-4 motifs in their structures, however,
the former acts as an anti-factor and the latter acts as
a pro-factor (Figure 1B, right). It has also been reported
that Bcl-2 has a dual role as both a cell protector and
a killer and that the ability to switch roles depends on
the Bcl-2’s subcellular localization (20,21). These facts
indicated that each motif did not directly link with the
speciﬁc function. Our previous study has also revealed the
capriciousness of the phenotype–genotype linkage of BH3
(7). Among the artiﬁcial proteins containing BH3, only
some clones showed pro-apoptotic activity, and their
apoptotic activity was not related to the number of motifs
in the proteins, but was aﬀected by the context of the
motif. Based on these facts, we thought that the linkage
between the motif and its phenotype would be weaker and
more ﬂexible than previously envisaged, and were inter-
ested in the possibility that the protein library constructed
from a common set of peptide motifs could represent the
‘promiscuous’ state of the protein (22,23) (Figure 1A). In
that sense, apoptotic regulatory proteins with disparate
functions (a protector and a killer) may have evolved from
such a promiscuous library. These considerations gave us
the idea that a combinatorial library created using the
BH1-4 motifs may contain both pro- and anti-apoptotic
proteins that oppositely regulate the intrinsic apoptosis
network (Figure 1C). We now report the functional
analyses of artiﬁcial proteins in the library prepared
from the BH1-4 motifs.
MATERIALS AND METHODS
Cell lines
Human cancer MCF-7 and HeLa cells were cultured at
378C in RPMI 1640 (GIBCO) or Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM, SIGMA) respectively. The
media were supplemented with 10% fetal bovine serum
(FBS, JRH Biosciences) and antibiotic/antimycotic solu-
tion (A5955, Sigma). The incubator contained air enriched
with 5% CO2.
Chemicals and reagents
Staurosporine (STS) and etoposide (VP-16) were
purchased from MBL and SIGMA, respectively. The
mouse monoclonal c-myc antibody (Ab-1) was from
Oncogene. The puriﬁed mouse anti-human PARP
[poly(ADP-ribose) polymerase] (clone 7D3-6) and anti-
cytochrome c (6H2.B4) monoclonal antibodies were from
BD Biosciences. The rabbit polyclonal anti-Bcl-xS/L (S-18)
and anti-Bax (N-20) antibodies were from Santa Cruz
Biotechnology.
Synthesis andexpressions of artificial proteins
We have recently developed a new motif programming
method, which enables the combinatorial polymerization
of multiple peptide motifs (12). Brieﬂy, segments of the
multiple single short DNA sequences, called microgene-
score, were ﬁrst designed so that they encode the peptide
motifs. These microgenescore were then used to create
paired microgene polymerization reaction (MPR) primers.
Because these primers have sequences that allow the
formation of base pairs in their 30 regions, they can
stochastically recreate multiple microgenes, so that when
the MPR is carried out, combinatorial polymers of
multiple microgenes are generated (12). Using this
method, microgenescore, which coded BH1-4, were
designed and then the MPR were carried out as previously
described. The microgene polymers were cloned into one
of three vectors (pcDNA 3.1/myc-His A, B or C;
Invitrogen) to add a myc epitope and a poly-histidine
tag at the C-terminal ends of the microgene products.
Derivatives of d29 by deletion of amino acids from the
N-terminus were constructed using the Kilo-sequence
deletion kit (Takara). The plasmids were transfected into
the MCF-7 cells or HeLa cells using lipofectamine 2000,
according to the manufacturer’s instructions (Invitrogen).
Screening forpro-and anti-apoptotic clones
Initially, proteins that inﬂuence the cell proliferation rate
were screened using MCF-7 cells that had been plated in
96-well plates ( 1 10
4 cells/well), pre-incubated for 24h
at 378C, and then transfected with plasmids (0.16mg)
encoding the target synthetic protein. The cells’ metabolic
activity was assayed after 48h by measuring the mito-
chondrial dehydrogenase activity using the tetrazolium
salt WST-1 according to the manufacturer’s (Roche)
instructions. To screen for proteins that down-regulate
apoptosis, the HeLa cells were plated and transfected with
each plasmid (0.1mg) as above in the presence or absence
of a plasmid encoding the pro-apoptotic human Bim
(50ng). As a positive control, cells were transfected with
a plasmid encoding anti-apoptotic human Bcl-xL. For
all assays, a plasmid containing no synthetic component
was used as the control.
Detectionof apoptosis
For the TdT-mediated dUTP nick end labeling (TUNEL)
assays, the MCF-7 cells were plated in 4-well permanox
Lab-tek chamber slides (0.5 10
5/well; NALGE NUNC)
and pre-incubated for 24h at 378C. After transfection with
the respective plasmids (0.8mg), the cells were incubated
for 48h and then ﬁxed in 4% paraformaldehyde (PFA).
An in situ Cell Death Detection Kit, Fluorescein (Roche)
was then used according to the manufacturer’s instruc-
tions. A plasmid encoding the pro-apoptotic human Bax
served as the positive control in Figure 2. To determine
the incidence of cell death shown in Figure 3, the MCF-7
cells plated in 6-well plates (1 10
6 cells/well) and pre-
incubated for 24h were transfected with the respective
plasmids (4mg) in the presence or absence of an anti-
apoptotic Bcl-xL plasmid. Dead cells ﬂoating in the
medium 52h later were counted, and that number was
divided by the total number of cells (1 10
6 cell/well).
In Figure 4, the HeLa cells were similarly plated and
transfected, after which 125 nM STS was added to the
Nucleic Acids Research, 2007, Vol. 35, No. 19 6359medium and incubated for an additional 24h. A TMR-red
in situ Cell Death Detection Kit (Roche) was then used to
detect the apoptotic cells.
Westernblotting
After transfecting the resultant plasmids into MCF-7 cells
plated in 6-well plates as described above, the cells were
lyzed for 30min on ice in 0.4ml of RIPA buﬀer (1 PBS,
1% NP 40, 0.5% sodium deoxycholate, 0.1% SDS,
0.1mg/ml PMSF and 30ml/ml aprotinin). The lyzed cells
were then centrifuged at 15000 g for 20min at 48C, and
the supernatant was used as the total cell lysate. The
concentration of proteins in each sample was normalized
using a DC-protein assay kit (BioRad). The membranes
were incubated with the mouse monoclonal anti-c-myc
antibody (1:1000, Oncogene), rabbit polyclonal anti-Bcl-
xS/L antibody (1:500, Santa Cruz) or a mouse monoclonal
anti-PARP antibody (1:500, BD Pharmingen).
Immunohistochemical analysis
For the immunohistochemical analysis summarized in
Figure 3, cells were ﬁxed in 4% PFA for 30min at room
temperature. The ﬁxed cells were permeabilized in PBS
containing 0.1% Triton X-100 for 3min at 48C, and then
incubated in blocking solution (PBS with 5% goat serum
and 0.3% Triton X-100) for 30min at room temperature.
The cells were then incubated ﬁrst for 1h at 378C with the
anti-cyto-c antibody (clone 6H2.B4, 1:200; Becton
Dickinson), rabbit anti-c-myc antibody (1:200; SIGMA)
or rabbit polyclonal anti-Bax (N-20) antibody (1:200),
after which they were incubated with either the FITC-
conjugated anti-mouse IgG (cytochrome-c, 1:200; ICN
Pharmaceuticals) or rhodamine-conjugated anti-rabbit
IgG (d29 or Bax, 1:200; Jackson Immuno Research).
In Figure 4, d16 or d29 was detected by incubating the
cells for 1h at 378C with a monoclonal mouse anti-c-myc
antibody (Ab-1, 1:200; Oncogene); Bcl-xL was detected
using a polyclonal rabbit anti-Bcl-xL antibody (S-18,
1:200; Santa Cruz Biotechnology). The cells were then
incubated with either the FITC-conjugated anti-mouse
(d16 or d29, 1:200; ICN Pharmaceuticals) or FITC-
conjugated anti-rabbit (Bcl-xL, 1:100; Molecular probes)
IgG. Stained samples were examined using a confocal
laser scanning microscope (TCS, SP2; Leica).
RESULTS
Screening forpro-apoptotic proteins
We have recently established a new motif programming
method, in which a library for artiﬁcial proteins was
synthesized from the combinatorial polymerization of
multiple peptide motifs (12). Using this method, we have
prepared a library for artiﬁcial proteins that contained
combinations of the BH1-4 motifs. In this preparation,
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Figure 2. A pro-apoptotic clone d29 created from a mixture of BH motifs. (A) Screening for pro-apoptotic clones. MCF-7 cells were transfected with
DNA (0.16mg) encoding the target protein (each of 28 clones) or empty vector (control). Cell viability was then evaluated using WST-1 assays. Bars
depict means SD from at least four independent experiments. (B) Schematic drawing of d29, a10 and d16 used in this study. (C) Expressions of
d29, a10 and d16. MCF-7 cells were transfected with DNA encoding d29, a10, d16 or empty vector and analyzed by western blotting. (D) Pro-
apoptotic function of d29. MCF-7 cells were initially transfected with DNA (0.8mg) encoding empty vector (control), Bax, d29 or a10. After 48h, the
cells were ﬁxed and changes in the cell morphology were correlated with TUNEL staining. (E) The incidence of apoptotic cells was counted using
TUNEL staining. Bars depict means SD from three independent experiments. (F) Expression of synthetic proteins was visualized using a confocal
microscope and anti-c-myc antibody (red). A good correlation was observed between TUNEL positivity and d29 expression.
6360 Nucleic Acids Research, 2007, Vol. 35, No. 19we extracted BH1, BH2 and BH4 motif (eight amino acids
each) from the human Bcl-xL (anti-apoptotic) (9), and
for BH3, we extracted nine amino acids from the human
Noxa (pro-apoptotic) (24) (BH1core-BH4core, Figure 1C,
middle). We used the BH3
Noxa motif to construct a library
because the simple conjugation of BH3
Noxa and the
protein transduction domain of the Tat protein (PTD
Tat)
has been shown to penetrate into cells, but failed to
induce apoptosis, whereas a combinatorial library con-
structed from these motifs contained bi-functional pro-
teins (7). Among the 41 created clones, 28 ( 70%) of
the clones had a stable product in human cells, which
was detectable by immunohistochemistry and western
blot (12).
Starting from these 28 clones, we ﬁrst screened for
clones having pro-apoptotic activity. For this purpose, we
transfected DNA for each clone to MCF-7 cells (human
breast cancer cells), and scored their viability after a 48h
incubation. From this analysis, we found that the viability
of the cells transfected with plasmid-d29 was reduced
to 60% of that seen with the control cells transfected with
the empty vector (Figure 2A). The predicted translation
product, d29, was composed of 221 amino acids; it
contained two BH3core, two BH1core and four BH4core
motifs, and had a myc epitope and a poly-histidine tag
at its C-terminus, (Figure 2B, Supplementary Figure 1
and Table 1). We analyzed the expressions of the d29-
transfected clones by western blotting and found that the
predicted length of the polypeptides was detected using an
anti-myc antibody (Figure 2C). An immunohistochemical
analysis conﬁrmed that the full-length of d29 was
eﬀectively expressed in human cells (Figure 2F, d29-Myc
and data not shown). Thus we further characterized the
function of d29. For comparison, we also examined the
eﬀects of the 139-amino acid a10 clone, which had two
BH3core and two BH4core motifs, but did not appear
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transfected with DNA encoding d29, Bax or empty vector (control), after which they were ﬁxed in 4% PFA, and d29 and cytochrome c were
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Cytochrome c was diﬀusely distributed within cells accumulating d29 or Bax, but showed a punctate distribution pattern corresponding to the
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Bcl-xL and poly (ADP-ribose) polymerase (PARP). PARP cleavage was induced by d29, and this pro-apoptotic activity was inhibited by the
co-expression of Bcl-xL.
Nucleic Acids Research, 2007, Vol. 35, No. 19 6361to inhibit cell growth (Figures 2A and B, and
Supplementary Figure 1), and Bax, which is known to
be one of the naturally occurring pro-apoptotic Bcl-2
family proteins (Figure 1B, right).
Forty-eight hours after transfecting the respective
plasmids into MCF-7 cells,  30% of the d29-transfectants
were apoptotic as indicated by their TUNEL positivity
(Figure 2D). In contrast, the incidence of TUNEL
positivity was less than 5% among the a10 transfectants
and control vector-transfected cells. The pro-apoptotic
eﬀect of d29 was similar to that of Bax (Figure 2E, 30%
versus 20%), and the morphological changes induced
by the d29 transfectants were also similar to that of
the Bax transfectants; cell shrinkage and condensation
of the nucleus were observed (Figure 2D, phase).
Immunostaining of the d29 transfectants with the anti-
myc antibody revealed a good correlation between the
TUNEL positivity and d29 accumulation whereas the a10
transfectants did not (Figure 2F). These results indicated
that d29 induces apoptosis in a human cancer cell.
The N-terminal motifs of d29 areindispensable
forthepro-apoptotic function
In order to identify the regions of d29 that are responsible
for the pro-apoptotic function, we constructed three
N-terminal truncated derivatives by deleting the
50 portions of the gene (d29-N26, -52, -77,
Figure 3A). The expression levels and localizations in
the MCF-7 cells were similar amongst those derivatives
and d29 (Figure 3A, lanes 1–4, and data not shown).
However, TUNEL staining showed that all of the d29
derivatives signiﬁcantly reduced the pro-apoptotic activity
that their parental d29 possesses (Figure 3B). One of
the derivatives had its N-terminal 26 residues deleted,
indicating that this short region containing the BH4core
and BH3core motifs is indispensable for the pro-apoptotic
activity of d29.
We next wondered whether d29 induced apoptosis
through the mitochondria-dependent pathways. Because
the release of cytochrome c from the mitochondria is an
essential marker for mitochondrial-dependent apoptosis
(Figure 1B), we investigated the localization pattern of
cytochrome c in the d29-transfected cells. Cells transfected
with the empty vector and stained with the anti-
cytochrome c or Mitotracker
TM exhibited overlapping
punctate distributions of cytochrome c and the mitochon-
drial, indicating that cytochrome c remained associated
with the mitochondria in the control cells (Figure 3C, top
and data not shown). In contrast, the distribution of
cytochrome c in cells transfected with the pro-apoptotic
protein d29 or Bax (stained by anti-myc or anti-Bax
antibodies) was diﬀuse, indicating the cytochrome c was
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6362 Nucleic Acids Research, 2007, Vol. 35, No. 19not tightly associated with the mitochondria in those
cells (Figure 3C, middle and bottom). Thus these results
suggest that the growth inhibition caused by d29 is due
to the induction of the mitochondria-dependent apoptosis.
d29 modulates Bcl-xL-dependent apoptosis network
Next we investigated whether the d29-modulated apopto-
sis network was regulated by Bcl-2 family proteins.
Although the apoptosis network in the mitochondria is
not completely understood and many unknown proteins
are likely to participate in this network (14), it is generally
accepted that the pro-apoptotic Bcl-2 family proteins are
crucially involved and that their pro-apoptotic activity is
negatively modulated by the anti-apoptotic Bcl-2 family
(e.g. Bcl-xL). In addition, overexpression of the anti-
apoptotic Bcl-2 family proteins often inhibit apoptosis
caused by the exogenous expression of the pro-apoptotic
Bcl-2 family proteins, which is consistent with the idea
that the relative levels of the pro- and anti-apoptotic
proteins determines the cell fate in the Bcl-2 family-
dependent apoptosis network (Figure 1B) (13). With that
in mind, we investigated the extent to which the d29-
induced apoptosis could be inhibited by the exogenous
expression of Bcl-xL. We found that when MCF-7 cells
were co-transfected with plasmids encoding d29 and
Bcl-xL, the growth inhibitory eﬀect of d29 was remark-
ably prevented (Figure 3D), and the d29-induced cell
death was also attenuated;  30% of the cells transfected
with d29 alone died, as compared to <10% of the cells
transfected with the d29 plus Bcl-xL (Figure 3E). We then
conﬁrmed the suppression of apoptosis in these cells
by assessing the levels of the cleaved PARP, a
hallmark of the activation of the executive caspases, key
apoptotic mediators. As expected, the level of the cleaved
PARP increased with the expression of d29 but was
reduced to the control levels by co-expression of Bcl-xL
(Figure 3F). To further investigate the possibility
that d29 acted via Bcl-proteins pathway, we carried out
co-immnoprecipitation (Co-IP) assay. From these assays,
we found that Bcl-xL was co-immunoprecipitated with
c-myc-tagged d29, suggesting that the interaction between
d29 and Bcl-xL was involved in the d29-induced apoptosis
(Supplementary Figure 2A). The d29 also induced
reduction of mitochondrial transmembrane potential
( m) in a similar manner to the pro-apoptotic Bax,
and loss of  m induced by d29 was partially reversed
by Bcl-xL overexpression. These results conﬁrmed that
d29 modulated Bcl-xL function and then activated Bcl-2
family-dependent apoptosis pathways (Supplementary
Figure 2B). Therefore, it appears that d29 crosstalks
with the intrinsic apoptosis circuits regulated by Bcl-xL
and thus the pro-apoptotic function of d29 reﬂects its
ability to modulate the apoptosis signaling networks
composed of the Bcl-2 family proteins.
Anti-apoptotic proteins generated from thesame library
To determine whether the above protein library generated
by motif programming also contained anti-apoptotic
proteins, we scored the capacity of the 28 clones to relieve
the growth inhibition caused by the naturally occurring
pro-apoptotic protein, Bim (25) (Figure 1B). In this
experiment, we used HeLa cells instead of MCF-7 cells
because Bcl-xL did not eﬃciently suppress the pro-
apoptotic activity of Bim in the MCF-7 cells, but did so
in HeLa cells (data not shown). The pro-apoptotic eﬀect
of the d29 transfectant was also conﬁrmed in the HeLa
cells (Figure 4C, d29, and data not shown). When we
transfected the HeLa cells with Bim alone, the cell viability
was only  40–60% of that seen with the control cells
(Figure 4A, +Bim). Interestingly, two clones (a10 and
d16, Figure 2B and Supplementary Figure 1) have been
screened for a potent anti-apoptotic modulator, because
the a10 or d16 plus Bim transfectants increased the
viability to 60–80% of the control cells under various
conditions, but the 26 other clones did not. (Figure 4A,
+ Bim and data not shown). Because it has been reported
that the exogenous expression of Bcl-xL eﬀectively
suppresses the apoptosis caused by anti-cancer drugs
and pro-apoptotic proteins, we also compared the eﬀects
of Bcl-xL to those of a10/d16 on the viability among the
cells treated with VP-16 or STS, which are known to
induce mitochondria-dependent apoptosis. Treating HeLa
cells transfected with an empty vector with either of
the drugs markedly reduced the viability, but the cell
viability was partially restored by transfection of a10 or
d16 (Figure 4A, +VP-16 and + STS), although the anti-
apoptotic activities of a10/d16 were moderate compared
to that of Bcl-xL. We further analyzed the apoptosis-
inhibitory eﬀect of d16. The d16 protein was composed of
164 amino acids and contained all of the BH1-4 motifs
(two BH1core, two BH2core, one BH3core, and ﬁve BH4core)
(Figure 2B). We analyzed the expressions of the d16-
transfected clones and conﬁrmed that the predicted
lengths of the polypeptides were detected (Figure 2C).
The anti-apoptotic eﬀect of the d16 transfectant was
conﬁrmed by TUNEL assays of the STS-treated cells.
A strong TUNEL signal (rhodamine ﬂuorescence; red)
was observed when the cells were transfected with the
empty vector and then incubated for 23h with 125nM
STS, but that the signal was signiﬁcantly diminished by
transfection of Bcl-xL or d16 (Figure 4B). In addition,
immunostaining with the anti-myc (for d16) or anti-Bcl-
xL antibody together with TUNEL showed that cells
expressing Bcl-xL or d16 were protected from the STS-
induced apoptosis (Figure 4C, Bcl-xL/d16, shown by
yellow arrows), which is consistent with the anti-apoptotic
activities of these proteins. We also investigated the
involvement of Bcl pathway in the anti-apoptotic activities
of a10 and d16. It is known that Bax activation
(the oligomerization of Bax) is essential for Bcl-2
family-dependent pathway. The oligomerization state of
Bax was determined by cross-linking and subsequent
immunoblot analysis. We conﬁrmed that a10/d16 modu-
lated Bax-dependent apoptosis pathways; Bax-transfected
cells induced Bax oligomerization, but the levels
of Bax oligomerization were reduced in Bax and a10
(d16)-co-transfected cells (Supplementary Figure 2C).
These conﬁrmed that a10/d16 also act via Bcl-2
family-dependent apoptosis pathways. Taken together,
our ﬁndings indicate that both the pro-apoptotic (d29)
and anti-apoptotic (a10/d16) proteins can be generated
Nucleic Acids Research, 2007, Vol. 35, No. 19 6363from a single library composed of a combinatorial
assemblage of four BH1-4core motifs (Figure 4D).
Diverse subcellular localizationsgenerated
bymotif programming
It has been reported that the Bcl-2 family proteins are
localized in a variety of cellular organelles even though
they share the same BH motifs (21). For instance, the
anti-apoptotic Bﬂ-1S and Bcl-xL, both of which contained
the BH1-4 motifs, mainly localize in the nucleus and
mitochondria, respectively (26). To investigate whether
diﬀerent arrangements of the BHcore motifs aﬀect the
subcellular localizations of artiﬁcial proteins, we
monitored the localizations of all of the 28 clones and
interestingly found that these proteins are localized in
a variety of organelles, including the nucleus, cytoplasm or
mitochondria (Figure 5 and summarized in Table 1). This
suggests that the artiﬁcial proteins were eﬀectively
expressed and formed stable products in cells, and then
translocated to the various intracellular compartments.
We have previously reported that the a8 protein exhibits
overlapping distributions with mitochondria (12). Three
other clones (a10, a12 and a14) also appeared to be
localized in the mitochondria, because Mitotracker
TM
merged with the localization patterns of these proteins
(Figure 5, top, and data not shown). However, these
proteins did not include naturally occurring mitochondria
targeting motifs (Supplementary Figure 1). The b6, b9, c2,
c8 and d5 proteins are localized in the nucleus whereas the
other proteins seemed to be localized in the cytoplasm
(Figure 5, middle and bottom). Thus the localizations
of proteins were dependent on how the microgenes were
joined together and how the reading frames appeared on
the microgene polymers (Supplementary Figure 1 and
Table 1). Although further structural and mutational
analyses will be necessary to fully elucidate the roles of
BH1-4core in the functions as well as localizations of these
proteins, it would be noteworthy that synthetic proteins
with diﬀerent function/localization patterns can emerge
from a single pool prepared from common peptide motifs.
DISCUSSION
Motifs are generally identiﬁed as evolutionally conserved
sequences in the primary structures of proteins (27).
As their identities have remained during the course of
evolution, motifs must have certain biological functions.
In proteins involved with signal transductions, motifs
Table 1. Properties of artiﬁcial proteins used in this study
Amino acid composition
Name Total residues Mw pI Positive
a Negative
b Localization
d29 221 24655 9.43 0.14 0.12 Cytoplasm
d29N26 195 21585 8.39 0.13 0.12 Cytoplasm
d29N52 169 18516 6.49 0.11 0.12 Cytoplasm
d29N77 144 15580 6.74 0.10 0.10 Cytoplasm
a10 139 15642 11.17 0.19 0.10 Mitochondria/cytoplasm
d16 164 19183 9.48 0.16 0.15 Cytoplasm
a8 142 16062 10.79 0.18 0.10 Mitochondria
a12 140 15642 10.7 0.19 0.14 Mitochondria
a14 242 26356 10.87 0.15 0.09 Mitochondria
b6 142 16836 6.8 0.15 0.16 Nucleus/ cytoplasm
b9 164 19058 11.82 0.21 0.08 Nucleus/ cytoplasm
c2 217 23070 5.61 0.08 0.11 Nucleus /cytoplasm
c8 216 23935 11.28 0.16 0.10 Nucleus/ cytoplasm
d5 193 22098 11.86 0.21 0.08 Nucleus
c27 168 18159 6.75 0.12 0.13 Cytoplasm
d15 171 19716 10.8 0.19 0.11 Cytoplasm
d19 117 13675 10.76 0.19 0.13 Cytoplasm
Molecular weights (Mw) were calculated from nucleotide sequences. Isoelectric points (pI) were calculated by ProtParam tool (http://au.expasy.org/
tools/protparam.html).
aLys and Arg.
bAsp and Glu.
a8
d19
a12
b6 b9 c8 d5
c27
c2
control a10 a14
d15 d16 d29
M
i
t
o
N
u
c
l
e
u
s
C
y
t
o
Figure 5. Investigating the relationship between protein sequences
and cellular localizations. For analysis of the protein localizations,
the MCF-7 cells were plated and pre-incubated for 24h at 378C. After
transfection with the respective plasmids (0.8mg) using lipofectamine
(2ml), the cells were incubated for 24h and then ﬁxed in 4% PFA.
The localizations of the synthetic proteins were analyzed using the
anti-myc antibody (see also Materials and Methods section for
Immunohistochemical Analysis). Schematic drawing of artiﬁcial
proteins is also shown.
6364 Nucleic Acids Research, 2007, Vol. 35, No. 19are often related to the sites for protein–protein interac-
tion (9,10), which underlie the complex, dynamic and
robust protein network (28).
Our motif programming is a method for creating
multifunctional proteins by virtue of the linkage between
motifs and their functions, i.e. realizing new combinations
of functions by combining motifs whose functions
have been already annotated (7,12,29,30). What we
learned from our past motif programming studies can be
summarized as follows: (i) tight protein folding is not
necessary for the expression of functions and (ii) expres-
sion of the motif function is inﬂuenced by the context of
the motif. We used our MolCraft (31) and its modiﬁed
method in the motif programming experiments (7,32,33).
In this methodology, motifs are embedded in diﬀerent
reading frames of a microgene or diﬀerent microgenes,
and the motifs are combinatorially assembled to make the
protein library. Proteins created from these methods are
usually disordered and not tightly folded, although they
often exhibit secondary structures (30). Nevertheless, we
observed that some of these artiﬁcial proteins exerted
biological functions such as cell penetration, apoptosis
and biomineralization (7,34). Thus, tight folding is not
necessary for a protein to express (at least some of)
biological functions.
Motif programming is the rational design of artiﬁcial
proteins. However, proteins containing embedded motifs
do not always possess the designed functions. For
instance, when the cell-penetrating motif PTD and
apoptosis-inducing motif BH3 were programmed to
make bifunctional proteins, a fraction of the clones in
the library showed distinct functions of cell penetrating
and apoptosis inducing (7). Most of them have moderate
function(s) irrespective of the contained motifs. The
strong expression of functions was not result from
multiplicities of the motif. Apparently, their functional
expression was inﬂuenced by where the motifs were
located in the proteins, i.e. inﬂuenced by the context of
the motif. Similar capriciousness has been observed in our
or others’ motif-based experiments (8). Thus, the function
annotated to the motifs seems to be no longer a mere
absolute when they are detached from their parental
bodies. Motifs must be in a promiscuous state in terms
of function.
These observations prompted us to investigate the
properties of the artiﬁcial library that we have prepared
from the BH1-4 motifs. The protein networks that
regulate the mitochondrial apoptosis contain combina-
tions of the BH1-4 motifs, and form a complex network
from various components. Although bewildering factors
are involved, the general principle is rather simple, that is,
the balance between the pro-apoptotic and anti-apoptotic
proteins determine the cell fate, i.e. either cell survival or
death. For instance, the function of the pro-apoptotic Bim
was attenuated by the ectopic expression of the anti-
apoptotic Bcl-xL (25). With these situations in mind, we
investigated how our 28 artiﬁcial clones, which have been
created by assembling the BH1-4 motifs, would inﬂuence
the intrinsic apoptosis signaling network. We observed
that the d29 clone showed a strong pro-apoptotic
activities and a10 and d16 showed a moderated,
but unambiguous anti-apoptotic activity. We clearly
found that the pro-apoptotic activity of d29 was
signiﬁcantly attenuated by the overexpression of Bcl-xL.
Conversely, the anti-apoptotic eﬀect of a10/d16 partially
blocked the eﬀect of the pro-apoptotic Bim and anti-
cancer drugs (STS or VP-16) in a manner similar to Bcl-
xL. Thus, disparate functions (a cell killer and a cell
protector) have emerged from a single pot of a protein
library. Because the existence of motifs in these clones was
not linked to their phenotypes, we believed that the
promiscuous state of a protein was realized in a motif-
shuﬄing library. Our ﬁnding suggests that peptide motifs
contributed to the accomplishment of the plastic evolva-
bility of the protein network.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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